Dr Reddy's Laboratories LtdAdd to My Watchlist

RDY:USNew YorkIndustry: Medical-Drugs
  • 51.15
    Last
  • 0.58  1.15%
    Today's Change
  • 50.57
    Previous Close
  • Today
     
    38.00
    53.67
    52 Week Low - High
8:04 pm ET 10/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding170 million
Market Cap$9 billion
Return on Equity ttm26.30%
Last Dividend$0.27
Dividend Yield ttm0.57
Relative Dividend Yield benchmark0.29
Dividend Ex-Date8/1/14
Dividend Pay Date8/15/14
Earnings
EPS: Year Actual ttm--
EPS: Year Est. 3/15 ttm135.626
 
EPS: Quarterly Actual 0.00
EPS: Quarterly Est. --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate28.03
Company Description
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
Revenue$132 billion
Net Income$22 billion
Total Assets$170 billion
Employees19,000
Web Sitewww.drreddys.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!